Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades
Abstract Background The timing of the launch of a new drug is an important factor that determines access for patients. We evaluated patient access to pharmaceuticals in 30 European markets over the past two decades. Methods Launch dates were extracted from the IQVIA (formerly IMS) database for 30 Eu...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12913-022-08866-7 |